FDA and industry collaboration: Identifying opportunities to further reduce reliance on nonhuman primates for nonclinical safety evaluations.
Regul Toxicol Pharmacol
; 138: 105327, 2023 Feb.
Article
in En
| MEDLINE
| ID: mdl-36586472
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Primates
/
COVID-19
Type of study:
Guideline
Limits:
Animals
/
Humans
Country/Region as subject:
America do norte
Language:
En
Journal:
Regul Toxicol Pharmacol
Year:
2023
Document type:
Article
Affiliation country:
United States
Country of publication:
Netherlands